McKesson looking to sell Rexall pharmacy chain in Canada report

BCFC/iStock Editorial via Getty Images McKesson Corp. ( NYSE: MCK ) has spoken with prospective buyers for its Rexall pharmacy chain in Canada, according to a Globe & Mail report on Thursday. Rexall, which McKesson ( MCK ) acquired in 2016 for $2.2 billion, operates about 400 pharmacies. McKesson ( MCK ) could continue to supply Rexall even after it sells the drugstore chain with its pharmaceutical distribution business, according to the report.

McKesson ( MCK ) is scheduled to report its Q3 results on Feb. 7. More on McKesson McKesson: GLP 1 Medications Tailwinds And Massive Share Repurchase McKesson Corporation (MCK) Q2 2024 Earnings Call Transcript McKesson Corporation 2024 Q2 Results Earnings Call Presentation Purdue Pharma bankruptcy settlement heads to Supreme Court review McKesson Non GAAP EPS of $6.90 beats by $0.75, revenue of $70.5B misses by $5.48B.